Effect of Heparin-Aspirin to prevent thrombosis of knee and hip arthroplasty

Study the results of using of heparin aspirin protocol to prevent deep vein thrombosis and pulmonary embolism in total knee and hip arthroplasty patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170109031845N2

Enrollment

100

Registered

2019-11-23

Start date

2019-11-21

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Deep vein thrombosis. Condition 2: Pulmonary embolism. Acute embolism and thrombosis of deep veins of lower extremity Pulmonary embolism

Interventions

Intervention group: The first 5 days after surgery with 5000 units of heparin twice daily and then aspirin tablets every 2 hours or sprays tablets daily and after routine discharge after 2, 6, 12 and

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Consent to participate in the study

Exclusion criteria

Exclusion criteria: Wound infection Failure to follow up and refer of patients High risk of thromboembolism High risk of cardiovascular disease

Design outcomes

Primary

Measure	Time frame
Effect of Heparin-Aspirin protocol. Timepoint: One month, two months and one year after surgery. Method of measurement: Check list.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbolfazl Bagherifard

Iran University of Medical Sciences

bagherifd@gmail.com+98 21 3354 2001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026